Literature DB >> 28082207

Prevalence of myotonic dystrophy type 1 in adults in western Sweden.

Christopher Lindberg1, Fredrik Bjerkne2.   

Abstract

Myotonic dystrophy type 1 (DM1) is the most common inherited muscle disorder in adults. The prevalence differs widely between countries, but a figure of 13/100.000 is most frequently cited. It is a multi-organ disorder classified into four categories: congenital, childhood, adult/classical and late-onset/mild. The purpose of this study was to estimate the total and age adjusted prevalence of DM1 in adults in western Sweden (the Västra Götaland Region, VGR) as well as in the city of Gothenburg and also in the VGR except Gothenburg. Patients with the diagnosis of DM1 in the VGR were traced by outpatient registers at the Neuromuscular Center, contacted by regular mail and thereafter telephone interviewed about organ manifestations in order to ascertain the age at onset and thus the disease category. Medical records were examined to obtain detail accuracy. We detected 230 adult DM1 patients in the VGR which gives a prevalence of 17.8/100.000. The prevalence of DM1 in Gothenburg was 14.1/100.000, which was significantly lower than in the remaining region which was 19.7/100.000. There was no gender difference. The age adjusted prevalence rates showed that DM1 is most prevalent in the age group 35-44 years (23.9/100.000) and 45-54 years (25.8/100.000). DM1 prevalence in the western Sweden thus seems to be somewhat higher than elsewhere in Europe, and is especially high in the less densely populated areas of the region. The disease burden in the community is larger than what was known previously.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Age adjusted; Myotonic dystrophy type 1; Prevalence; Sweden

Mesh:

Year:  2016        PMID: 28082207     DOI: 10.1016/j.nmd.2016.12.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.

Authors:  Youjin Wang; Ruth M Pfeiffer; Rotana Alsaggaf; Wilhelmine Meeraus; Julia C Gage; Lesley A Anderson; Renée C Bremer; Nikoletta Nikolenko; Hanns Lochmuller; Mark H Greene; Shahinaz M Gadalla
Journal:  Int J Cancer       Date:  2017-11-20       Impact factor: 7.396

2.  Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.

Authors:  Erik Landfeldt; Josefin Edström; Cecilia Jimenez-Moreno; Baziel G M van Engelen; Janbernd Kirschner; Hanns Lochmüller
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

3.  The prevalence of hereditary neuromuscular disorders in Northern Norway.

Authors:  Kai Ivar Müller; Marijke Van Ghelue; Irene Lund; Christoffer Jonsrud; Kjell Arne Arntzen
Journal:  Brain Behav       Date:  2020-11-13       Impact factor: 2.708

4.  Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.

Authors:  Ji Yoon Han; Woori Jang; Joonhong Park
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

5.  The role of noninvasive ventilation in the management of type II respiratory failure in patients with myotonic dystrophy.

Authors:  Vilma Rautemaa; Mark E Roberts; Andrew Bentley; Timothy W Felton
Journal:  ERJ Open Res       Date:  2021-07-26

6.  Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis.

Authors:  K Gutschmidt; S Wenninger; F Montagnese; B Schoser
Journal:  J Neurol       Date:  2020-08-26       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.